Susquehanna International Group, LLP Edgewise Therapeutics, Inc. Call Options Transaction History

Susquehanna International Group, LLP

  • $560 Billion
  • Q3 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$15.88 - $29.5 $3.57 Million - $6.64 Million
225,000 Added 646.55%
259,800 $6.93 Million
Q2 2024

Aug 15, 2024
BUY
$15.08 - $21.23 $524,784 - $738,804
34,800 New
34,800 $626,000
Q2 2023

Aug 11, 2023
BUY
$5.71 - $10.29 $85,650 - $154,350
15,000 New
15,000 $116,000

Others Institutions Holding EWTX

# of Institutions
191
Shares Held
100M
Call Options Held
2.17M
Put Options Held
410K
View Full List

About Edgewise Therapeutics, Inc.

EWTX Quotes by TradingView
  • Ticker EWTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 63,171,700
  • Market Cap $1.82B
  • Description
  • Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...
More about EWTX
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email